We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation

Delisted

AGTC was delisted on the 30th of November, 2022.

94 hedge funds and large institutions have $153M invested in Applied Genetic Technologies Corporation in 2016 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 44 increasing their positions, 26 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 26

63% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 8

4% more funds holding

Funds holding: 9094 (+4)

4% more capital invested

Capital invested by funds: $147M → $153M (+$6.5M)

Holders
94
Holders Change
+4
Holders Change %
+4.44%
% of All Funds
2.51%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
44
Reduced
26
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
$1.69M +$755K +48,400 +68%
TC
27
TFS Capital
Pennsylvania
$1.58M -$883K -56,587 -34%
CWG
28
C WorldWide Group
Denmark
$1.46M
IHM
29
Iguana Healthcare Management
New York
$1.41M
TCIM
30
TIAA CREF Investment Management
New York
$1.33M +$201K +12,882 +16%
AllianceBernstein
31
AllianceBernstein
Tennessee
$1.2M +$1.12M +71,880 +561%
Allianz Asset Management
32
Allianz Asset Management
Germany
$1.19M +$516K +33,065 +65%
Millennium Management
33
Millennium Management
New York
$1.15M -$772K -49,496 -38%
GC
34
Globeflex Capital
California
$997K +$1.1M +70,554 New
Schroder Investment Management Group
35
Schroder Investment Management Group
United Kingdom
$976K +$1.08M +69,048 New
Citadel Advisors
36
Citadel Advisors
Florida
$953K -$222K -14,206 -17%
Morgan Stanley
37
Morgan Stanley
New York
$933K +$399K +25,557 +63%
AQR Capital Management
38
AQR Capital Management
Connecticut
$848K -$347K -22,223 -27%
ARTA
39
A.R.T. Advisors
New York
$833K +$490K +31,400 +114%
BA
40
BlackRock Advisors
Delaware
$728K +$164K +10,516 +26%
Deutsche Bank
41
Deutsche Bank
Germany
$727K -$330K -21,148 -29%
Goldman Sachs
42
Goldman Sachs
New York
$719K +$224K +14,357 +39%
BIM
43
BlackRock Investment Management
Delaware
$689K +$281K +18,034 +59%
Bank of New York Mellon
44
Bank of New York Mellon
New York
$665K +$33.2K +2,126 +5%
CCM
45
Cadence Capital Management
Massachusetts
$654K +$722K +46,268 New
TAM
46
Tocqueville Asset Management
New York
$607K -$54.6K -3,500 -8%
SO
47
STRS Ohio
Ohio
$597K +$23.4K +1,500 +4%
Bank of Montreal
48
Bank of Montreal
Ontario, Canada
$565K +$127K +8,162 +26%
DCM
49
Dupont Capital Management
Delaware
$516K +$570K +36,509 New
Massachusetts Financial Services
50
Massachusetts Financial Services
Massachusetts
$442K +$488K +31,301 New

AGTC Hedge Fund Activity: Q2 2016 in Review

94 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q2 2016, worth a combined $153M — up 4.4% from $147M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new AGTC positions and 8 closed out — a net gain of 5 holders — while 44 added to existing stakes and 26 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $3.16M. The largest seller was RA Capital Management, exiting entirely with an estimated $3.3M sold.

  • 94 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q2 2016, up from 90 in Q1 2016.
  • Funds reported $153M of Applied Genetic Technologies Corporation stock for Q2 2016, up 4.4% quarter-over-quarter.
  • 13 funds opened new Applied Genetic Technologies Corporation positions in Q2 2016 and 8 closed out, a net change of +5 holders.
  • The largest Applied Genetic Technologies Corporation buyer in Q2 2016 was Acadian Asset Management, an estimated $3.16M added.
  • The largest Applied Genetic Technologies Corporation seller in Q2 2016 was RA Capital Management, an estimated $3.3M sold.

Based on aggregated 13F filings for Q2 2016.